Jamil Khurram

Chief Medical OfficerGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Dec 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$137K
Net Open-Market Flow
-$137K
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)6K$2.20$14K6K
Dec 17, 2025Sell(S)9K$7.04$60K0
Dec 17, 2025Option exercise(M)9K$2.50$21K9K
Dec 17, 2025Sell(S)6K$7.04$45K0
Dec 17, 2025Sell(S)4K$7.04$32K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 17, 2025Option exercise(M)9K$050K
Dec 17, 2025Option exercise(M)6K$0102K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-25-000069) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about GALT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001133416-25-000069"
Ask your agent
Use Arkolith to summarize insider buying and selling at GALECTIN THERAPEUTICS INC
over the last 90 days and cite the filings.